−2.71USD
−109.06 MUSD
10.16 M
About Pharvaris N.V.
Sector
CEO
Berndt A. E. Modig
Headquarters
Leiden
Website
Employees (FY)
82
Founded
2015
ISIN
NL00150005Y4
FIGI
BBG00YYCW1N8
Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PHVS is 18.42 USD — it has decreased by 13.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pharvaris N.V. stocks are traded under the ticker PHVS.
Pharvaris N.V. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
PHVS stock is 15.69% volatile and has beta coefficient of 1.24. Check out the list of the most volatile stocks — is Pharvaris N.V. there?
One year price forecast for Pharvaris N.V. has a max estimate of 49.62 USD and a min estimate of 12.69 USD.
PHVS earnings for the last quarter are −0.61 USD whereas the estimation was −0.64 USD which accounts for 3.93% surprise. Estimated earnings for the next quarter are −0.59 USD. See more details about Pharvaris N.V. earnings.
Yes, you can track Pharvaris N.V. financials in yearly and quarterly reports right on TradingView.
PHVS stock has fallen by 23.06% compared to the previous week, the month change is a 25.88% fall, over the last year Pharvaris N.V. has showed a 118.25% increase.
PHVS net income for the last quarter is −35.22 M USD, while the quarter before that showed −25.67 M USD of net income which accounts for −37.19% change. Track more Pharvaris N.V. financial stats to get the full picture.
Today Pharvaris N.V. has the market capitalization of 752.58 M, it has increased by 2.66% over the last week.
No, PHVS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PHVS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharvaris N.V. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 82.00 employees. See our rating of the largest employees — is Pharvaris N.V. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharvaris N.V. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharvaris N.V. stock shows the sell signal. See more of Pharvaris N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Pharvaris N.V. future price: according to them, PHVS price has a max estimate of 49.62 USD and a min estimate of 12.69 USD. Read a more detailed Pharvaris N.V. forecast: see what analysts think of Pharvaris N.V. and suggest that you do with its stocks.